Parallax Volatility Advisers, L.P. Sarepta Therapeutics, Inc. Transaction History

Parallax Volatility Advisers, L.P.

$53.5 Billion
Q3 2024

A detailed history of Parallax Volatility Advisers, L.P. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Parallax Volatility Advisers, L.P. holds 5,000 shares of SRPT stock, worth $568,600. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,000

Previous 5,000 -0.0%

Holding current value

$568,600

Previous $790,000 21.01%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $47,970 - $57,840	468 New	468 $56,000
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $80,995 - $114,264	1,292 Added 38.69%	4,631 $347,000
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $71,801 - $102,807	1,137 Added 51.63%	3,339 $261,000
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $145,265 - $203,640	2,202 New	2,202 $204,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $856,957 - $2 Million	-11,861 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $1.03 Million - $2.4 Million	-14,224 Reduced 54.53%	11,861 $884,000
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $3.28 Million - $4.66 Million	26,085 New	26,085 $4.45 Million
Q4 2020 Feb 16, 2021	SELL	$125.56 - $178.74 $440,841 - $627,556	-3,511 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $443,140 - $600,777	-3,486 Reduced 49.82%	3,511 $493,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $1.66 Million - $2.65 Million	-20,118 Reduced 74.2%	6,997 $684,000
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $1.71 Million - $3.03 Million	22,328 Added 466.43%	27,115 $3.5 Million
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $610,220 - $1.32 Million	-8,381 Reduced 63.65%	4,787 $360,000
Q2 2019 Aug 14, 2019	BUY	$112.21 - $151.95 $1.18 Million - $1.6 Million	10,533 Added 399.73%	13,168 $2 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $867,440 - $1.23 Million	-8,132 Reduced 75.53%	2,635 $314,000
Q2 2018 Aug 14, 2018	SELL	$71.74 - $153.69 $225,263 - $482,586	-3,140 Reduced 22.58%	10,767 $1.42 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $410,799 - $489,355	8,623 Added 163.19%	13,907 $774,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $188,797 - $249,140	5,284	5,284 $240,000

Others Institutions Holding SRPT

# of Institutions

525

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account

Parallax Volatility Advisers, L.P. Sarepta Therapeutics, Inc. Transaction History